These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11888598)

  • 1. African scientists discuss drug-resistant malaria.
    Wendo C
    Lancet; 2002 Mar; 359(9308):770. PubMed ID: 11888598
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G; Landscheidt H; Glasner H
    Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
    [No Abstract]   [Full Text] [Related]  

  • 3. Malaria. Chloroquine makes a comeback.
    Vogel G
    Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
    [No Abstract]   [Full Text] [Related]  

  • 4. Multi-drug resistant malaria in Sri Lanka.
    Gunasekera DP; Perera DP
    Ceylon Med J; 1996 Dec; 41(4):170-1. PubMed ID: 9141768
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of antimalarial drugs.
    Baird JK
    N Engl J Med; 2005 Apr; 352(15):1565-77. PubMed ID: 15829537
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
    Hansford CF
    S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.
    Schapira A; Schwalbach JF
    Bull World Health Organ; 1988; 66(2):219-26. PubMed ID: 3293827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 10. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
    Turner GD
    Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG; Schröder K; Beltzner B
    Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495
    [No Abstract]   [Full Text] [Related]  

  • 17. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug resistant tropical malaria in the Republic of Guinea (West Africa)].
    Popov AF; Popova NI; Chirkov VP; Kamara F
    Med Parazitol (Mosk); 2003; (2):41-3. PubMed ID: 12886592
    [No Abstract]   [Full Text] [Related]  

  • 20. Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
    Delacollette C; Cibanguka J; Buregea H; Nkera J
    Acta Leiden; 1987; 55():159-62. PubMed ID: 3321832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.